4D pharma’s biotherapeutic may boost cancer immunotherapies, study suggests 13-Jul-2021 By Will Chu 4D pharma’s Live Biotherapeutic Product (LBP), appears to enhance anti-tumour activity and increase the efficacy of an immunotherapy used to treat certain tumours, says a German research team.